Identification of an inhibitor of neovascularization from cartilage - PubMed (original) (raw)
. 1990 Jun 15;248(4961):1408-10.
doi: 10.1126/science.1694043.
Affiliations
- PMID: 1694043
- DOI: 10.1126/science.1694043
Identification of an inhibitor of neovascularization from cartilage
M A Moses et al. Science. 1990.
Abstract
Certain tissues such as cartilage are resistant to vascular invasion, yet no single tissue-derived molecule that can inhibit angiogenesis has been reported. A protein derived from cartilage was purified that inhibits angiogenesis in vivo and capillary endothelial cell proliferation and migration in vitro in three separate bioassays. This protein is also an inhibitor of mammalian collagenase. These findings may help elucidate the mechanisms by which neovascularization is controlled in both normal and pathological states.
Similar articles
- [Tumor necrotic factor as an inhibitor of angiogenesis].
Sopotsinskaia EB, Lisniak IA. Sopotsinskaia EB, et al. Patol Fiziol Eksp Ter. 1988 Sep-Oct;(5):62-4. Patol Fiziol Eksp Ter. 1988. PMID: 2464155 Russian. No abstract available. - Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A. Hagedorn M, et al. Cancer Res. 2002 Dec 1;62(23):6884-90. Cancer Res. 2002. PMID: 12460903 - Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B. Anand-Apte B, et al. Invest Ophthalmol Vis Sci. 1997 Apr;38(5):817-23. Invest Ophthalmol Vis Sci. 1997. PMID: 9112976 - Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo.
Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. Ribatti D, et al. Anat Rec. 2001 Dec 1;264(4):317-24. doi: 10.1002/ar.10021. Anat Rec. 2001. PMID: 11745087 Review. - [Anti-tumor factors in cartilage].
Enomoto M, Takigawa M. Enomoto M, et al. Tanpakushitsu Kakusan Koso. 1987 Jul;32(8):1060-6. Tanpakushitsu Kakusan Koso. 1987. PMID: 3313522 Review. Japanese. No abstract available.
Cited by
- In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis.
Bacharach E, Itin A, Keshet E. Bacharach E, et al. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10686-90. doi: 10.1073/pnas.89.22.10686. Proc Natl Acad Sci U S A. 1992. PMID: 1279689 Free PMC article. - Forty-year journey of angiogenesis translational research.
Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B, Dvorak H, Langer R. Cao Y, et al. Sci Transl Med. 2011 Dec 21;3(114):114rv3. doi: 10.1126/scitranslmed.3003149. Sci Transl Med. 2011. PMID: 22190240 Free PMC article. Review. - Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.
Albini A, Indraccolo S, Noonan DM, Pfeffer U. Albini A, et al. Clin Exp Metastasis. 2010 Aug;27(6):419-39. doi: 10.1007/s10585-010-9312-5. Epub 2010 Apr 10. Clin Exp Metastasis. 2010. PMID: 20383568 Review. - Local anti-angiogenic brain tumor therapies.
Sipos EP, Brem H. Sipos EP, et al. J Neurooncol. 2000 Oct-Nov;50(1-2):181-8. doi: 10.1023/a:1006482120049. J Neurooncol. 2000. PMID: 11245278 Review. - Matrix metalloproteinase inhibitors: present achievements and future prospects.
Denis LJ, Verweij J. Denis LJ, et al. Invest New Drugs. 1997;15(3):175-85. doi: 10.1023/a:1005855905442. Invest New Drugs. 1997. PMID: 9387040 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources